1. Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
- Author
-
McFarlane, William R, Levin, Bruce, Travis, Lori, Lucas, F Lee, Lynch, Sarah, Verdi, Mary, Williams, Deanna, Adelsheim, Steven, Calkins, Roderick, Carter, Cameron S, Cornblatt, Barbara, Taylor, Stephan F, Auther, Andrea M, McFarland, Bentson, Melton, Ryan, Migliorati, Margaret, Niendam, Tara, Ragland, J Daniel, Sale, Tamara, Salvador, Melina, and Spring, Elizabeth
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Comparative Effectiveness Research ,Brain Disorders ,Clinical Research ,Clinical Trials and Supportive Activities ,Pediatric ,Prevention ,Pediatric Research Initiative ,Mental health ,Good Health and Well Being ,Adolescent ,Adult ,Anti-Anxiety Agents ,Antidepressive Agents ,Antimanic Agents ,Antipsychotic Agents ,Anxiety Disorders ,Child ,Community Mental Health Services ,Early Diagnosis ,Early Medical Intervention ,Employment ,Supported ,Family Therapy ,Female ,Humans ,Longitudinal Studies ,Male ,Mood Disorders ,Psychotic Disorders ,Severity of Illness Index ,Treatment Outcome ,Young Adult ,schizophrenia ,family psychoeducation ,multifamily group ,supported education ,supported employment ,assertive community treatment ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Clinical sciences - Abstract
ObjectiveTo test effectiveness of the Early Detection, Intervention, and Prevention of Psychosis Program in preventing the onset of severe psychosis and improving functioning in a national sample of at-risk youth.MethodsIn a risk-based allocation study design, 337 youth (age 12-25) at risk of psychosis were assigned to treatment groups based on severity of positive symptoms. Those at clinically higher risk (CHR) or having an early first episode of psychosis (EFEP) were assigned to receive Family-aided Assertive Community Treatment (FACT); those at clinically lower risk (CLR) were assigned to receive community care. Between-groups differences on outcome variables were adjusted statistically according to regression-discontinuity procedures and evaluated using the Global Test Procedure that combined all symptom and functional measures.ResultsA total of 337 young people (mean age: 16.6) were assigned to the treatment group (CHR + EFEP, n = 250) or comparison group (CLR, n = 87). On the primary variable, positive symptoms, after 2 years FACT, were superior to community care (2 df, p < .0001) for both CHR (p = .0034) and EFEP (p < .0001) subgroups. Rates of conversion (6.3% CHR vs 2.3% CLR) and first negative event (25% CHR vs 22% CLR) were low but did not differ. FACT was superior in the Global Test (p = .0007; p = .024 for CHR and p = .0002 for EFEP, vs CLR) and in improvement in participation in work and school (p = .025).ConclusionFACT is effective in improving positive, negative, disorganized and general symptoms, Global Assessment of Functioning, work and school participation and global outcome in youth at risk for, or experiencing very early, psychosis.
- Published
- 2015